Literature DB >> 21573921

New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.

Takeshi Sano1, Takashi Aiko.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21573921     DOI： 10.1007/s10120-011-0040-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  16 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.

Authors:  M Sasako; P McCulloch; T Kinoshita; K Maruyama
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Authors:  Hye Seong Ahn; Hyuk-Joon Lee; Seokyung Hahn; Woo-Ho Kim; Kuhn Uk Lee; Takeshi Sano; Stephen B Edge; Han-Kwang Yang
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

7.  Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Authors:  Jaffer A Ajani; Wuilbert Rodriguez; Gyorgy Bodoky; Vladimir Moiseyenko; Mikhail Lichinitser; Vera Gorbunova; Ihor Vynnychenko; August Garin; Istvan Lang; Silvia Falcon
Journal:  J Clin Oncol       Date:  2010-02-16       Impact factor: 44.544

8.  Gastric cancer treatment guidelines in Japan.

Authors:  Toshifusa Nakajima
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

9.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

10.  Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Authors:  Hiroyuki Narahara; Hiroyasu Iishi; Hiroshi Imamura; Akira Tsuburaya; Keisho Chin; Haruhiko Imamoto; Taito Esaki; Hiroshi Furukawa; Chikuma Hamada; Yuh Sakata
Journal:  Gastric Cancer       Date:  2011-02-23       Impact factor: 7.370
View more
  123 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Risk factors for 6-month continuation of S-1 adjuvant chemotherapy for gastric cancer.

Authors:  Toru Aoyama; Takaki Yoshikawa; Tsutomu Hayashi; Hiroshi Kuwabara; Yo Mikayama; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya
Journal:  Gastric Cancer       Date:  2012-04-21       Impact factor: 7.370

3.  Feasible endoscopic therapy for early gastric cancer.

Authors:  Tian-Jiao Guo; Jin-Yu Qin; Lin-Lin Zhu; Jin Wang; Jin-Lin Yang; Yi-Ping Wang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

4.  Short and long-term outcomes after gastrectomy for gastric carcinoma in elderly patients.

Authors:  Bo Shu; Sanlin Lei; Fazhao Li; Songwen Hua; Yong Chen; Zhi Huo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy.

Authors:  Guang-Tan Lin; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

6.  Prognostic factors for stage IV gastric cancer.

Authors:  Hiroyuki Baba; Koki Kuwabara; Toru Ishiguro; Kensuke Kumamoto; Yoichi Kumagai; Keiichiro Ishibashi; Norihiro Haga; Hideyuki Ishida
Journal:  Int Surg       Date:  2013 Apr-Jun

7.  Clinicopathologic characteristics and prognosis of gastric cancer in young patients.

Authors:  Hiroaki Saito; Seigo Takaya; Yoji Fukumoto; Tomohiro Osaki; Shigeru Tatebe; Masahide Ikeguchi
Journal:  Yonago Acta Med       Date:  2012-09-30       Impact factor: 1.641

Review 8.  Minimally invasive surgery for gastric cancer.

Authors:  Ali Güner; Woo Jin Hyung
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

9.  Postoperative intra-abdominal complications assessed by the Clavien-Dindo classification following open and laparoscopy-assisted distal gastrectomy for early gastric cancer.

Authors:  Masanori Tokunaga; Junya Kondo; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  J Gastrointest Surg       Date:  2012-07-31       Impact factor: 3.452

10.  Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers.

Authors:  Yasuyuki Shigematsu; Tohru Niwa; Satoshi Yamashita; Hirokazu Taniguchi; Ryoji Kushima; Hitoshi Katai; Seiji Ito; Tetsuya Tsukamoto; Masao Ichinose; Toshikazu Ushijima
Journal:  Oncol Lett       Date:  2012-05-09       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.